−2.00 TWD
−84.89 M TWD
27.02 M TWD
About U-NEURON BIOMEDICAL INC
Sector
CEO
Hsiao Min Huang
Website
Headquarters
New Taipei
Founded
2015
ISIN
TW0006973001
FIGI
BBG01HDNB8S6
U-Neuron Biomedical, Inc. engages in the research and development of stem cell storage and separation technology, and treatment application technology. It focuses in the study of Amniotic Fluid Stem Cells, Olfactory Stem Cells, and Adipose-derived Stem Cells. The company was founded on September 4, 2015 and is headquartered in New Taipei, Taiwan.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 6973 is 39.40 TWD — it has increased by 1.03% in the past 24 hours. Watch U-NEURON BIOMEDICAL INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange U-NEURON BIOMEDICAL INC stocks are traded under the ticker 6973.
6973 stock has fallen by −2.72% compared to the previous week, the month change is a 0.13% rise, over the last year U-NEURON BIOMEDICAL INC has showed a −32.58% decrease.
6973 reached its all-time high on Dec 22, 2023 with the price of 61.70 TWD, and its all-time low was 35.95 TWD and was reached on Jul 24, 2023. View more price dynamics on 6973 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
6973 stock is 2.42% volatile and has beta coefficient of 0.25. Track U-NEURON BIOMEDICAL INC stock price on the chart and check out the list of the most volatile stocks — is U-NEURON BIOMEDICAL INC there?
Today U-NEURON BIOMEDICAL INC has the market capitalization of 1.54 B, it has decreased by −1.22% over the last week.
Yes, you can track U-NEURON BIOMEDICAL INC financials in yearly and quarterly reports right on TradingView.
6973 net income for the last half-year is −32.34 M TWD, while the previous report showed −28.82 M TWD of net income which accounts for −12.21% change. Track more U-NEURON BIOMEDICAL INC financial stats to get the full picture.
No, 6973 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. U-NEURON BIOMEDICAL INC EBITDA is −60.84 M TWD, and current EBITDA margin is −308.47%. See more stats in U-NEURON BIOMEDICAL INC financial statements.
Like other stocks, 6973 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade U-NEURON BIOMEDICAL INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So U-NEURON BIOMEDICAL INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating U-NEURON BIOMEDICAL INC stock shows the neutral signal. See more of U-NEURON BIOMEDICAL INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.